Titel

Merkliste
1 Ergebnisse

Matching weight-adjusted incidence rates and hazard ratios ..:

Catherine G. Derington (6649580) ; Jordana B. Cohen (10692408) ; April F. Mohanty (10692411)...
https://figshare.com/articles/dataset/Matching_weight-adjusted_incidence_rates_and_hazard_ratios_for_the_primary_and_secondary_outcomes_among_outpatient_Veterans_with_treated_hypertension_who_were_current_users_of_an_ARB_ACEI-_vs_non-ARB_ACEI-based_antihypertensive_regimen_and_/14475720. , 2021

Link: https://doi.org/10.1371/journal.pone.0248080.t001

RT Journal
T1 <Title>Matching weight-adjusted incidence rates and hazard ratios for the primary and secondary outcomes among outpatient Veterans with treated hypertension who were current users of an ARB/ACEI- vs. non-ARB/ACEI-based antihypertensive regimen and ARB user vs. ACEI user, separately</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14475720&Exemplar=1&LAN=DE
				
A1 Catherine G. Derington (6649580)
A1 Jordana B. Cohen (10692408)
A1 April F. Mohanty (10692411)
A1 Tom H. Greene (7923863)
A1 James Cook (257569)
A1 Jian Ying (159396)
A1 Guo Wei (79839)
A1 Jennifer S. Herrick (10692414)
A1 Vanessa W. Stevens (10692417)
A1 Barbara E. Jones (10692420)
A1 Libo Wang (605513)
A1 Alexander R. Zheutlin (10692423)
A1 Andrew M. South (10692426)
A1 Thomas C. Hanff (10692429)
A1 Steven M. Smith (10692432)
A1 Rhonda M. Cooper-DeHoff (7400735)
A1 Jordan B. King (9727905)
A1 G. Caleb Alexander (7854044)
A1 Dan R. Berlowitz (10692435)
A1 Faraz S. Ahmad (10349068)
A1 M. Jason Penrod (10692438)
A1 Rachel Hess (235431)
A1 Molly B. Conroy (10191922)
A1 James C. Fang (6821441)
A1 Michael A. Rubin (8397342)
A1 Srinivasan Beddhu (70253)
A1 Alfred K. Cheung (8617534)
A1 Weiming Xian (10692441)
A1 William S. Weintraub (7931513)
A1 Adam P. Bress (4853035)
YR 2021
K1 Medicine
K1 Cell Biology
K1 Neuroscience
K1 Biotechnology
K1 Cancer
K1 Virology
K1 100 person-months
K1 syndrome coronavirus 2
K1 angiotensin-converting enzyme inhib
K1 HR
K1 propensity score-weighted Cox regre
K1 2.0 all-cause deaths
K1 ACEI use
K1 follow-up 30 days
K1 SARS-CoV -2 infection
K1 retrospective cohort study
K1 Veterans Background Angiotensin II
K1 coronavirus disease 2019
K1 COVID -19-related outcomes
K1 17.7 all-cause deaths
K1 100 person months
K1 outpatient
K1 vs
K1 follow-up 87 days
K1 CI
K1 inpatient
K1 Angiotensin II receptor blocker
K1 follow-up 85 days
K1 user
K1 ARB
JF https://figshare.com/articles/dataset/Matching_weight-adjusted_incidence_rates_and_hazard_ratios_for_the_primary_and_secondary_outcomes_among_outpatient_Veterans_with_treated_hypertension_who_were_current_users_of_an_ARB_ACEI-_vs_non-ARB_ACEI-based_antihypertensive_regimen_and_/14475720
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0248080.t001
DO https://doi.org/10.1371/journal.pone.0248080.t001
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)